查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球非甾體抗炎藥市場規模、份額和行業趨勢分析報告：2022-2028 年按給藥途徑、分銷渠道、適應症和地區的展望和預測
市場調查報告書
商品編碼
1115332

全球非甾體抗炎藥市場規模、份額和行業趨勢分析報告：2022-2028 年按給藥途徑、分銷渠道、適應症和地區的展望和預測

Global Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Distribution Channel, By Route of Disease Indication, By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 225 Pages | 訂單完成後即時交付

價格

到 2028 年，全球非甾體抗炎藥的市場規模預計將達到 255 億美元，在預測期內以 5.7% 的複合年增長率增長。

預計慢性疼痛的患病率在預測期內將增加，從而推動 NSAID 市場的增長。例如，CDC 估計，2019 年美國約有 20.4% 的成年人經歷過慢性疼痛。與年齡相關的慢性疼痛患病率增加在 65 歲及以上人群中最為明顯。與西班牙裔、非西班牙裔亞洲人和非西班牙裔黑人相比，非西班牙裔白人的慢性疼痛患病率最高。大約 23.6% 的非西班牙裔白人成年人患有慢性不適。因此，鑑於 COX-2 選擇性和非選擇性 NSAID 經常用於治療慢性疼痛，預計慢性疼痛患病率的增加將推動增長。

COVID-19 影響分析

傳染病 COVID-19 於 12 月下旬在中國湖北武漢首次出現。 SARS-CoV-2 是導致急性呼吸系統綜合症的病毒，具有高度傳染性，可在人與人之間傳播。自 2019 年 12 月爆發以來，該病毒已傳播到 213 個國家，並被世界衛生組織列為大流行病。世界各地的政府以及製藥和生物技術公司正在共同努力抗擊 COVID-19 疫情，從管理醫療供應鏈到幫助創建疫苗。因此，預計對 COVID-19 疫苗及其療法的需求將推動製藥和生物技術行業向前發展。

市場增長因素

慢性疼痛的發病率增加

在沒有藥物或治療的情況下持續超過 12 週的疼痛稱為慢性或持續性疼痛。有些人從受傷或手術的痛苦中恢復過來，重新站起來。然而，即使沒有事故或手術史，疼痛也可能持續很長時間或突然出現。非甾體抗炎藥市場擴張的主要驅動力之一是引起疼痛和炎症的疾病患病率上升。這些藥劑經常用於治療急性和慢性疼痛。布洛芬和雙氯芬酸是兩種經常被推薦用於治療疼痛的藥物。

越來越多的人更喜歡非甾體抗炎藥而不是阿片類藥物。

非甾體抗炎藥和阿片類藥物最常用於治療輕度至重度疼痛。然而，阿片類藥物的使用與嚴重的不良事件有關。自數千年前文明出現以來，阿片類藥物就被用於緩解疼痛。阿片類鎮痛劑經常用於治療鈍痛、非局部疼痛，通常是腹痛。頻繁使用會導致藥物耐受和依賴，突然停止使用阿片類止痛藥會導致戒斷症狀。不含阿片類藥物的非甾體抗炎藥 (NSAID) 是最常用的鎮痛藥，用於治療疼痛。在高劑量時，這些藥物還具有解熱、鎮痛和抗炎作用。

市場製約因素

由於 Nsaids 的副作用限制消費

使用非甾體抗炎藥的副作用，如過敏反應、胃痛、胃潰瘍和頭暈，預計將抑制市場增長。非甾體抗炎藥因其可用性和抗炎特性而成為處方最多的藥物之一。然而，與非甾體抗炎藥相關的胃腸道問題在全球範圍內呈顯著上升趨勢，可能會給醫療保健系統帶來壓力。緊急住院的最常見原因是與非甾體抗炎藥相關的胃腸道出血。而且，它的副作用使其成為美國最典型的藥物副作用。

疾病適應症的前景

非甾體抗炎藥市場根據適應症分為關節炎、偏頭痛、眼病等。 2021年，關節炎板塊在非甾體抗炎藥市場的收入份額最高。關節炎和骨關節炎的總體發病率、全球人口老齡化的增加、非甾體抗炎藥的高處方率以及局部關節炎治療的日益普及，都促成了這一領域的增長。

管理路線展望

非甾體抗炎藥市場按給藥途徑分為口服、局部和其他。 2021年，口服部分將佔據非甾體抗炎藥市場最大的收入份額。這是由於大量口服非甾體抗炎藥可用於治療疼痛、頭痛、發燒和偏頭痛，以及非處方藥非甾體抗炎藥的銷售量不斷增加。為了治療頭痛和偏頭痛，強生消費品公司提供非甾體抗炎藥 Motrin（布洛芬），它有片劑、液體凝膠、膠囊和溶液等劑型。

分銷渠道前景

非甾體抗炎藥市場按分銷渠道分為醫院藥店、零售藥店和在線藥店。 2021 年，醫院藥房部門在非甾體抗炎藥市場中佔據了重要的收入份額。這是因為非甾體類抗炎藥被廣泛用於治療住院患者的疼痛。與此同時，世界各地越來越多的醫院將在預測期內加速該行業的增長。

區域展望

按地區分析了北美、歐洲、亞太地區和 LAMEA 的非甾體抗炎藥市場。北美已成為非甾體抗炎藥市場的關鍵地區，2021 年收入份額最大。影響市場增長的關鍵變量包括大量製造商的存在和行業參與者的戰略行動。此外，預計關節炎和慢性疼痛的患病率在預測期內將增加，從而加速增長。

內容

第一章市場範圍和研究方法

  • 市場定義。
  • 目的。
  • 市場規模。
  • 細分。
    • 按給藥途徑分列的非甾體抗炎藥全球市場
    • 按分銷渠道劃分的非甾體抗炎藥全球市場
    • 按疾病適應症劃分的非甾體抗炎藥全球市場
    • 按地區分列的非甾體抗炎藥全球市場
  • 調查方法

第 2 章市場概述

  • 簡介。
    • 概覽
      • 市場構成和情景。
  • 影響市場的主要因素。
    • 市場驅動因素。
    • 市場限制因素。

第 3 章非甾體抗炎藥市場的最新策略

第 4 章非甾體抗炎藥的全球市場：按給藥途徑

  • 全球口服藥物市場：按地區
  • 全球外用藥物市場：按地區劃分
  • 世界其他地區的世界市場

第 5 章非甾體抗炎藥全球市場：按分銷渠道劃分

  • 按地區分列的全球零售藥店市場
  • 全球醫院內藥房市場：按地區劃分
  • 全球在線藥店市場：按地區劃分

第 6 章非甾體抗炎藥全球市場：疾病適應症

  • 世界關節炎市場：按地區
  • 全球偏頭痛市場：按地區
  • 全球眼病市場：按地區
  • 世界其他地區的世界市場

第 7 章全球非甾體抗炎藥市場：按地區劃分

  • 北美。
    • 按國家/地區分列的北美非甾體抗炎藥市場
      • 美國
      • 加拿大
      • 墨西哥
      • 北美以外的地區
  • 歐洲
    • 按國家/地區分列的歐洲非甾體抗炎藥市場
      • 德國
      • 英國
      • 法國
      • 俄羅斯
      • 西班牙
      • 意大利
      • 其他歐洲
  • 亞太地區
    • 按國家/地區分列的亞太地區非甾體抗炎藥市場
      • 中國
      • 日本
      • 印度
      • 韓國
      • 新加坡
      • 馬來西亞
      • 其他亞太地區
  • LAMEA
    • LAMEA 非甾體抗炎藥市場：按國家/地區分類
      • 巴西
      • 阿根廷
      • 阿聯酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亞
      • LAMEA 其他地區

第 8 章公司簡介

  • Dr. Reddy's Laboratories Ltd.
  • Pfizer, Inc.
  • GlaxoSmithKline PLC
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly And Company
  • Sanofi S.A.
  • AstraZeneca PLC
  • Viatris, Inc.
  • Merck & Co., Inc.

The Global Non-Steroidal Anti-inflammatory Drugs Market size is expected to reach $25.5 billion by 2028, rising at a market growth of 5.7% CAGR during the forecast period.

Non-steroidal anti-inflammatory medications (NSAIDs) are used to alleviate pain, lower fevers, and improve blood circulation. Furthermore, the inflammation is decreased when high dosages of non-steroidal anti-inflammatory medicines (NSAIDs) are given. Non-steroidal medications have sedative and anti-inflammatory effects. Inflammation is caused by the COX-1 and COX-2 enzymes that are inhibited by non-steroidal anti-inflammatory medications (NSAIDs). Aspirin, naproxen, ibuprofen, and paracetamol are examples of typical non-steroidal anti-inflammatory medications.

The market for non-steroidal anti-inflammatory medications (NSAIDs) is expanding as a result of a number of causes, including the growing incidence of chronic pain worldwide and an ageing population. The expanding use of NSAIDs for headache, toothache, migraine, and menstrual pain, as well as growing preference for OTC NSAIDs, are also anticipated to contribute to the growth over the forecast period. Additionally, the accessibility of a wide range of NSAID products as well as an increase in product approvals and launches are projected to fuel growth over the forecast period.

During the projected period, the prevalence of chronic pain is anticipated to increase, driving NSAID market growth. For instance, the CDC estimates that in the United States, about 20,4% of adults experienced chronic pain in 2019. Age-related increases in the prevalence of chronic pain were most pronounced in persons 65 years of age and older. Compared to Hispanic, non-Hispanic Asian, and non-Hispanic black individuals, non-Hispanic whites had the highest prevalence of chronic pain. About 23.6 percent of non-Hispanic white adults suffer from chronic discomfort. Therefore, given that both COX-2 selective and non-selective NSAIDs are frequently employed in the management of chronic pain, the increasing prevalence of chronic pain is anticipated to promote growth.

COVID-19 Impact Analysis

The infectious disease COVID-19 first surfaced in late December in the Chinese city of Wuhan's Hubei province. SARS-CoV-2, the virus that causes the acute respiratory syndrome is extremely contagious and spreads from person to person. The virus has spread to 213 nations since its outbreak in December 2019, prompting the World Health Organization to classify it as a pandemic. Governments and pharmaceutical and biotech businesses from all around the world are collaborating to combat the COVID-19 outbreak, from managing the medical supply chain to assisting in the creation of vaccinations. As a result, the demand for the COVID-19 vaccination and its treatment medications is predicted to propel the pharmaceutical and biotechnology sectors forward.

Market Growth Factors

Growing Incidence Of Chronic Pain

Pain that persists for more than 12 weeks without medication or treatment is referred to as chronic or persistent pain. Several people recover from pain due to injuries or operation and return to normalcy. However, there are situations when the pain lasts longer or appears suddenly without any prior history of an accident or surgery. One of the key factors propelling the market expansion for non-steroidal anti-inflammatory medications is the rising prevalence of disorders that cause pain and inflammation. These medications are being used more frequently to treat both acute & chronic pain. Ibuprofen & diclofenac are two medications that are frequently recommended to treat pain.

Increasing Preference Of People For Nsaids Over Opioids

The most often recommended medications for the management of mild to severe pain are NSAIDs and opioids. Opioid use, however, is linked to serious adverse outcomes. Since the dawn of civilization thousands of years ago, opioids have been used to relieve pain. Opioid analgesics are frequently used to treat dull, ill-localized pain, typically abdominal pain. Frequent doses may result in drug tolerance and dependency, and abruptly stopping an opioid painkiller may trigger a withdrawal crisis. Non-opioid, non-steroidal anti-inflammatory medicines (NSAIDs), which do not include opioids, are the most often prescribed analgesics for the management of pain. At larger doses, these medications also have antipyretic, analgesics, and anti-inflammatory properties.

Market Restraining Factors

Adverse Effects Of Nsaids Would Restrict Its Consumption

The market growth is anticipated to be constrained by adverse reactions to NSAID use, including allergic reactions, stomach pain, stomach ulcers, and dizziness. These pharmaceuticals are one of the most often prescribed medicines due to their widespread accessibility and anti-inflammatory effects. However, NSAID-related gastrointestinal issues are on the rise significantly globally, which could put a strain on the healthcare system. The most frequent reason for the most of emergency hospital admissions is GI bleeding related to NSAIDs. Additionally, its side effect is the most typical drug side in the United States.

Disease Indication Outlook

Based on disease indication, the Non-steroidal Anti-inflammatory Drugs Market is segmented into Arthritis, Migraine, Ophthalmic Diseases and Others. The arthritis segment acquired the highest revenue share in the Non-steroidal Anti-inflammatory Drugs Market in 2021. The overall incidence of arthritis & osteoarthritis, the growing senior population worldwide, the strong prescription rate for NSAIDs, and the rise in popularity of topical arthritis treatments are all contributing factors to the segment's growth.

Route of Administration Outlook

By Route of Administration, the Non-steroidal Anti-inflammatory Drugs Market is classified into Oral, Topical and Others. The oral segment garnered the maximum revenue share in the Non-steroidal Anti-inflammatory Drugs Market in 2021. It is due to the abundance of oral NSAIDs available for treating pain, headaches, fever, and migraines as well as the rise in OTC NSAID sales. To treat headaches and migraines, Johnson & Johnson Consumer Inc. provides their NSAID medication Motrin (ibuprofen), which is offered in dose forms such a tablet, liquid gel, capsule, and solution.

 

Distribution Channel Outlook

On the basis of distribution channel, the Non-steroidal Anti-inflammatory Drugs Market is divided into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. The hospital pharmacy segment acquired a significant revenue share in the Non-steroidal Anti-inflammatory Drugs Market in 2021. It is because non-steroidal anti-inflammatory medications are widely used to treat pain in hospitalized patients. Along with that, the rise in the number of hospitals across various nations of the world would escalate the growth of the segment over the forecast period.

Regional Outlook

Region-wise, the Non-steroidal Anti-inflammatory Drugs Market is analyzed across North America, Europe, Asia Pacific and LAMEA. North America emerged as the leading region in the Non-steroidal Anti-inflammatory Drugs Market with the maximum revenue share in 2021. Some of the key variables influencing the market's growth include the existence of a sizable number of manufacturers and the strategic actions made by industry participants. In addition, it is predicted that the prevalence of arthritis and chronic pain will rise during the forecast period, accelerating growth.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Dr. Reddy's Laboratories Ltd., Pfizer, Inc., GlaxoSmithKline PLC, Bayer AG, Teva Pharmaceuticals Industries Ltd., Eli Lilly And Company, Sanofi S.A., AstraZeneca PLC, Viatris, Inc., and Merck & Co., Inc.

Recent Strategies deployed in Non-steroidal Anti-inflammatory Drugs Market

Partnerships, Collaborations and Agreements:

May-2022: Dr. Reddy's Laboratories formed a partnership with South Korea-based HK inno.N Corporation. Through this partnership, Tegoprazan would offer a new option for the treatment of gastric acid-related as well as mobility-impaired diseases like Erosive/Non-erosive Gastroesophageal Reflux Disease (GERD / NERD), Nonsteroidal anti-inflammatory drug-mediated ulcers, Gastric and Duodenal ulcers, and Helicobacter pylori eradication.

Product Launches and Product Expansions:

Aug-2021: Dr Reddy's Laboratories introduced over-the-counter (OTC) Naproxen Sodium Tablets USP, 220 mg, the store-brand equivalent of Aleve, in the US market. This tablet is an over-the-counter non-steroidal anti-inflammatory drug (NSAID) for usage as a pain reliever and fever reducer.

May-2022: Dr. Reddy's Laboratories released Ketorolac Tromethamine Tablets USP, 10 mg, a therapeutic generic equivalent of the reference listed drug Toradol Tablets, 10 mg in the U.S. market. This product is a nonsteroidal anti-inflammatory drug (NSAID) demonstrated for the short-term management of moderately serious acute pain, which offers analgesia at the opioid stage and only as continuation treatment after intravenous or intramuscular dosing of ketorolac tromethamine, if necessary.

Approvals and Trails:

Feb-2022: Bayer received approval for Kerendia in the EU for adult people with chronic kidney disease related to type 2 diabetes. Kerendia is non-steroidal, which is a selective mineralocorticoid receptor (MR) antagonist to demonstrate positive kidney and cardiovascular (CV) results.

Jan-2022: Pfizer received approval from the United States (U.S.) Food and Drug Administration (FDA) for CIBINQO, an oral, once-daily, Janus kinase 1 (JAK1) inhibitor. CIBINQO is recommended for doses of 100 mg and 200 mg, along with the 200 mg dose being recommended for people for whom the medicine of 100 mg dose is less effective.

Dec-2020: GlaxoSmithKline got approval for BENLYSTA from the US Food and Drug Administration (FDA). This product is launched for the treatment of adult patients with active lupus nephritis (LN) who are getting standard therapy.

Sep-2020: Pfizer got the approval for XELJANZ from the United States (U.S.) Food and Drug Administration (FDA). This product is for the treatment of children and adolescents 2 years and elder with active polyarticular course juvenile idiopathic arthritis (pcJIA). In addition, the approval would make XELJANZ the first and only Janus kinase (JAK) inhibitor approved in the U.S. for the treatment of pcJIA.

Mar-2020: GlaxoSmithKline received approval from the U.S. Food and Drug Administration (FDA) for Advil Dual Action with Acetaminophen as an over-the-counter (OTC) product for pain relief. This product would offer relief for various symptoms and is the first formulation, which integrates ibuprofen and acetaminophen, two powerful ingredients related to OTC pain relief that would work in multiple ways.

Feb-2020: GlaxoSmithKline got approval from the U.S. Food and Drug Administration (FDA) for Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID)- arthritis pain reliever). This product is an over-the-counter (OTC) product for the temporary relief of arthritis pain in the hand, elbow, wrist, ankle foot, or knee in adults.

Scope of the Study

Market Segments covered in the Report:

By Route of Administration

  • Oral
  • Topical
  • Others

By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

By Disease Indication

  • Arthritis
  • Migraine
  • Ophthalmic Diseases
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Dr. Reddy's Laboratories Ltd.
  • Pfizer, Inc.
  • GlaxoSmithKline PLC
  • Bayer AG
  • Teva Pharmaceuticals Industries Ltd.
  • Eli Lilly And Company
  • Sanofi S.A.
  • AstraZeneca PLC
  • Viatris, Inc.
  • Merck & Co., Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Non-steroidal Anti-inflammatory Drugs Market, by Route of Administration
    • 1.4.2 Global Non-steroidal Anti-inflammatory Drugs Market, by Distribution Channel
    • 1.4.3 Global Non-steroidal Anti-inflammatory Drugs Market, by Disease Indication
    • 1.4.4 Global Non-steroidal Anti-inflammatory Drugs Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Recent Strategies deployed in Non-steroidal Anti-inflammatory Drugs Market

Chapter 4. Global Non-steroidal Anti-inflammatory Drugs Market by Route of Administration

  • 4.1 Global Oral Market by Region
  • 4.2 Global Topical Market by Region
  • 4.3 Global Others Market by Region

Chapter 5. Global Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel

  • 5.1 Global Retail Pharmacy Market by Region
  • 5.2 Global Hospital Pharmacy Market by Region
  • 5.3 Global Online Pharmacy Market by Region

Chapter 6. Global Non-steroidal Anti-inflammatory Drugs Market by Disease Indication

  • 6.1 Global Arthritis Market by Region
  • 6.2 Global Migraine Market by Region
  • 6.3 Global Ophthalmic Diseases Market by Region
  • 6.4 Global Others Market by Region

Chapter 7. Global Non-steroidal Anti-inflammatory Drugs Market by Region

  • 7.1 North America Non-steroidal Anti-inflammatory Drugs Market
    • 7.1.1 North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
      • 7.1.1.1 North America Oral Market by Country
      • 7.1.1.2 North America Topical Market by Country
      • 7.1.1.3 North America Others Market by Country
    • 7.1.2 North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
      • 7.1.2.1 North America Retail Pharmacy Market by Country
      • 7.1.2.2 North America Hospital Pharmacy Market by Country
      • 7.1.2.3 North America Online Pharmacy Market by Country
    • 7.1.3 North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.1.3.1 North America Arthritis Market by Country
      • 7.1.3.2 North America Migraine Market by Country
      • 7.1.3.3 North America Ophthalmic Diseases Market by Country
      • 7.1.3.4 North America Others Market by Country
    • 7.1.4 North America Non-steroidal Anti-inflammatory Drugs Market by Country
      • 7.1.4.1 US Non-steroidal Anti-inflammatory Drugs Market
        • 7.1.4.1.1 US Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.1.4.1.2 US Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.1.4.1.3 US Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.1.4.2 Canada Non-steroidal Anti-inflammatory Drugs Market
        • 7.1.4.2.1 Canada Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.1.4.2.2 Canada Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.1.4.2.3 Canada Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.1.4.3 Mexico Non-steroidal Anti-inflammatory Drugs Market
        • 7.1.4.3.1 Mexico Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.1.4.3.2 Mexico Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.1.4.3.3 Mexico Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.1.4.4 Rest of North America Non-steroidal Anti-inflammatory Drugs Market
        • 7.1.4.4.1 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.1.4.4.2 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.1.4.4.3 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  • 7.2 Europe Non-steroidal Anti-inflammatory Drugs Market
    • 7.2.1 Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
      • 7.2.1.1 Europe Oral Market by Country
      • 7.2.1.2 Europe Topical Market by Country
      • 7.2.1.3 Europe Others Market by Country
    • 7.2.2 Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
      • 7.2.2.1 Europe Retail Pharmacy Market by Country
      • 7.2.2.2 Europe Hospital Pharmacy Market by Country
      • 7.2.2.3 Europe Online Pharmacy Market by Country
    • 7.2.3 Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.2.3.1 Europe Arthritis Market by Country
      • 7.2.3.2 Europe Migraine Market by Country
      • 7.2.3.3 Europe Ophthalmic Diseases Market by Country
      • 7.2.3.4 Europe Others Market by Country
    • 7.2.4 Europe Non-steroidal Anti-inflammatory Drugs Market by Country
      • 7.2.4.1 Germany Non-steroidal Anti-inflammatory Drugs Market
        • 7.2.4.1.1 Germany Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.2.4.1.2 Germany Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.2.4.1.3 Germany Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.2.4.2 UK Non-steroidal Anti-inflammatory Drugs Market
        • 7.2.4.2.1 UK Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.2.4.2.2 UK Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.2.4.2.3 UK Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.2.4.3 France Non-steroidal Anti-inflammatory Drugs Market
        • 7.2.4.3.1 France Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.2.4.3.2 France Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.2.4.3.3 France Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.2.4.4 Russia Non-steroidal Anti-inflammatory Drugs Market
        • 7.2.4.4.1 Russia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.2.4.4.2 Russia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.2.4.4.3 Russia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.2.4.5 Spain Non-steroidal Anti-inflammatory Drugs Market
        • 7.2.4.5.1 Spain Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.2.4.5.2 Spain Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.2.4.5.3 Spain Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.2.4.6 Italy Non-steroidal Anti-inflammatory Drugs Market
        • 7.2.4.6.1 Italy Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.2.4.6.2 Italy Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.2.4.6.3 Italy Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.2.4.7 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market
        • 7.2.4.7.1 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.2.4.7.2 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.2.4.7.3 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  • 7.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market
    • 7.3.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
      • 7.3.1.1 Asia Pacific Oral Market by Country
      • 7.3.1.2 Asia Pacific Topical Market by Country
      • 7.3.1.3 Asia Pacific Others Market by Country
    • 7.3.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
      • 7.3.2.1 Asia Pacific Retail Pharmacy Market by Country
      • 7.3.2.2 Asia Pacific Hospital Pharmacy Market by Country
      • 7.3.2.3 Asia Pacific Online Pharmacy Market by Country
    • 7.3.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.3.3.1 Asia Pacific Arthritis Market by Country
      • 7.3.3.2 Asia Pacific Migraine Market by Country
      • 7.3.3.3 Asia Pacific Ophthalmic Diseases Market by Country
      • 7.3.3.4 Asia Pacific Others Market by Country
    • 7.3.4 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Country
      • 7.3.4.1 China Non-steroidal Anti-inflammatory Drugs Market
        • 7.3.4.1.1 China Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.3.4.1.2 China Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.3.4.1.3 China Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.3.4.2 Japan Non-steroidal Anti-inflammatory Drugs Market
        • 7.3.4.2.1 Japan Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.3.4.2.2 Japan Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.3.4.2.3 Japan Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.3.4.3 India Non-steroidal Anti-inflammatory Drugs Market
        • 7.3.4.3.1 India Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.3.4.3.2 India Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.3.4.3.3 India Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.3.4.4 South Korea Non-steroidal Anti-inflammatory Drugs Market
        • 7.3.4.4.1 South Korea Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.3.4.4.2 South Korea Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.3.4.4.3 South Korea Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.3.4.5 Singapore Non-steroidal Anti-inflammatory Drugs Market
        • 7.3.4.5.1 Singapore Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.3.4.5.2 Singapore Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.3.4.5.3 Singapore Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.3.4.6 Malaysia Non-steroidal Anti-inflammatory Drugs Market
        • 7.3.4.6.1 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.3.4.6.2 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.3.4.6.3 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.3.4.7 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market
        • 7.3.4.7.1 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.3.4.7.2 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.3.4.7.3 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  • 7.4 LAMEA Non-steroidal Anti-inflammatory Drugs Market
    • 7.4.1 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
      • 7.4.1.1 LAMEA Oral Market by Country
      • 7.4.1.2 LAMEA Topical Market by Country
      • 7.4.1.3 LAMEA Others Market by Country
    • 7.4.2 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
      • 7.4.2.1 LAMEA Retail Pharmacy Market by Country
      • 7.4.2.2 LAMEA Hospital Pharmacy Market by Country
      • 7.4.2.3 LAMEA Online Pharmacy Market by Country
    • 7.4.3 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.4.3.1 LAMEA Arthritis Market by Country
      • 7.4.3.2 LAMEA Migraine Market by Country
      • 7.4.3.3 LAMEA Ophthalmic Diseases Market by Country
      • 7.4.3.4 LAMEA Others Market by Country
    • 7.4.4 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Country
      • 7.4.4.1 Brazil Non-steroidal Anti-inflammatory Drugs Market
        • 7.4.4.1.1 Brazil Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.4.4.1.2 Brazil Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.4.4.1.3 Brazil Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.4.4.2 Argentina Non-steroidal Anti-inflammatory Drugs Market
        • 7.4.4.2.1 Argentina Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.4.4.2.2 Argentina Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.4.4.2.3 Argentina Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.4.4.3 UAE Non-steroidal Anti-inflammatory Drugs Market
        • 7.4.4.3.1 UAE Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.4.4.3.2 UAE Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.4.4.3.3 UAE Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.4.4.4 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market
        • 7.4.4.4.1 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.4.4.4.2 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.4.4.4.3 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.4.4.5 South Africa Non-steroidal Anti-inflammatory Drugs Market
        • 7.4.4.5.1 South Africa Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.4.4.5.2 South Africa Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.4.4.5.3 South Africa Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.4.4.6 Nigeria Non-steroidal Anti-inflammatory Drugs Market
        • 7.4.4.6.1 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.4.4.6.2 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.4.4.6.3 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.4.4.7 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market
        • 7.4.4.7.1 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.4.4.7.2 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.4.4.7.3 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication

Chapter 8. Company Profiles

  • 8.1 Dr. Reddy's Laboratories Ltd.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Partnerships, Collaborations, and Agreements:
      • 8.1.5.2 Product Launches and Product Expansions:
  • 8.2 Pfizer, Inc.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Regional & Segmental Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Approvals and Trails:
  • 8.3 GlaxoSmithKline PLC
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Approvals and Trails:
  • 8.4 Bayer AG
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expense
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Approvals and Trails:
  • 8.5 Teva Pharmaceutical Industries Ltd.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Regional Analysis
    • 8.5.4 Research & Development Expenses
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Product Launches and Product Expansions:
  • 8.6 Eli Lilly And Company
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Regional Analysis
    • 8.6.4 Research & Development Expenses
    • 8.6.5 Recent strategies and developments:
      • 8.6.5.1 Approvals and Trails:
  • 8.7 Sanofi S.A.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expense
  • 8.8 AstraZeneca PLC
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Regional Analysis
    • 8.8.4 Research & Development Expenses
  • 8.9 Viatris, Inc.
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis
    • 8.9.4 Research & Development Expense
  • 8.10. Merck & Co., Inc.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Segmental and Regional Analysis
    • 8.10.4 Research & Development Expenses

LIST OF TABLES

  • TABLE 1 Global Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 2 Global Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 3 Global Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 4 Global Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 5 Global Oral Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Oral Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Topical Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Topical Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 12 Global Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 13 Global Retail Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Retail Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Hospital Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Hospital Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Online Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Online Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 20 Global Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 21 Global Arthritis Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Arthritis Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Migraine Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Migraine Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Ophthalmic Diseases Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Ophthalmic Diseases Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 29 Global Non-steroidal Anti-inflammatory Drugs Market by Region, 2018 - 2021, USD Million
  • TABLE 30 Global Non-steroidal Anti-inflammatory Drugs Market by Region, 2022 - 2028, USD Million
  • TABLE 31 North America Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 32 North America Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 33 North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 34 North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 35 North America Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 37 North America Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 40 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 41 North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 42 North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 43 North America Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 45 North America Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 46 North America Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 47 North America Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 49 North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 50 North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 51 North America Arthritis Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Arthritis Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Migraine Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Migraine Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Ophthalmic Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 56 North America Ophthalmic Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 57 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 58 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 59 North America Non-steroidal Anti-inflammatory Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 60 North America Non-steroidal Anti-inflammatory Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 61 US Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 62 US Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 63 US Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 64 US Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 65 US Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 66 US Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 67 US Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 68 US Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 69 Canada Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 70 Canada Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 71 Canada Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 72 Canada Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 73 Canada Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 74 Canada Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 75 Canada Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 76 Canada Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 77 Mexico Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 78 Mexico Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 79 Mexico Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 80 Mexico Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 81 Mexico Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 82 Mexico Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 83 Mexico Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 84 Mexico Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 85 Rest of North America Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 86 Rest of North America Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 87 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 88 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 89 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 90 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 91 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 92 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 93 Europe Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 94 Europe Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 95 Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 96 Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 97 Europe Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 98 Europe Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 99 Europe Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 100 Europe Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 101 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 102 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 103 Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 104 Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 105 Europe Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 106 Europe Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 107 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 108 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 109 Europe Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 110 Europe Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 111 Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 112 Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 113 Europe Arthritis Market by Country, 2018 - 2021, USD Million
  • TABLE 114 Europe Arthritis Market by Country, 2022 - 2028, USD Million
  • TABLE 115 Europe Migraine Market by Country, 2018 - 2021, USD Million
  • TABLE 116 Europe Migraine Market by Country, 2022 - 2028, USD Million
  • TABLE 117 Europe Ophthalmic Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 118 Europe Ophthalmic Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 119 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 120 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 121 Europe Non-steroidal Anti-inflammatory Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 122 Europe Non-steroidal Anti-inflammatory Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 123 Germany Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 124 Germany Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 125 Germany Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 126 Germany Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 127 Germany Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 128 Germany Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 129 Germany Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 130 Germany Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 131 UK Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 132 UK Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 133 UK Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 134 UK Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 135 UK Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 136 UK Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 137 UK Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 138 UK Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 139 France Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 140 France Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 141 France Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 142 France Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 143 France Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 144 France Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 145 France Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 146 France Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 147 Russia Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 148 Russia Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 149 Russia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 150 Russia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 151 Russia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 152 Russia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 153 Russia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 154 Russia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 155 Spain Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 156 Spain Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 157 Spain Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 158 Spain Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 159 Spain Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 160 Spain Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 161 Spain Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 162 Spain Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 163 Italy Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 164 Italy Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 165 Italy Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 166 Italy Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 167 Italy Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 168 Italy Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 169 Italy Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 170 Italy Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 171 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 172 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 173 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 174 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 175 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 176 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 177 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 178 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 179 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 180 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 181 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 182 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 183 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 184 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 185 Asia Pacific Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 186 Asia Pacific Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 187 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 188 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 189 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 190 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 191 Asia Pacific Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 192 Asia Pacific Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 193 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 194 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 195 Asia Pacific Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 196 Asia Pacific Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 197 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 198 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 199 Asia Pacific Arthritis Market by Country, 2018 - 2021, USD Million
  • TABLE 200 Asia Pacific Arthritis Market by Country, 2022 - 2028, USD Million
  • TABLE 201 Asia Pacific Migraine Market by Country, 2018 - 2021, USD Million
  • TABLE 202 Asia Pacific Migraine Market by Country, 2022 - 2028, USD Million
  • TABLE 203 Asia Pacific Ophthalmic Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 204 Asia Pacific Ophthalmic Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 205 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 206 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 207 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 208 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 209 China Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 210 China Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 211 China Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 212 China Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 213 China Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 214 China Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 215 China Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 216 China Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 217 Japan Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 218 Japan Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 219 Japan Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 220 Japan Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 221 Japan Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 222 Japan Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 223 Japan Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 224 Japan Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 225 India Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 226 India Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 227 India Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 228 India Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 229 India Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 230 India Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 231 India Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 232 India Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 233 South Korea Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 234 South Korea Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 235 South Korea Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 236 South Korea Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 237 South Korea Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 238 South Korea Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 239 South Korea Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 240 South Korea Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 241 Singapore Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 242 Singapore Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 243 Singapore Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 244 Singapore Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 245 Singapore Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 246 Singapore Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 247 Singapore Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 248 Singapore Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 249 Malaysia Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 250 Malaysia Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 251 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 252 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 253 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 254 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 255 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 256 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 257 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 258 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 259 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 260 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 261 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 262 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 263 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 264 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 265 LAMEA Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 266 LAMEA Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 267 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 268 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 269 LAMEA Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 270 LAMEA Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 271 LAMEA Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 272 LAMEA Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 273 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 274 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 275 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 276 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 277 LAMEA Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 278 LAMEA Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 279 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 280 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 281 LAMEA Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 282 LAMEA Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 283 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 284 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 285 LAMEA Arthritis Market by Country, 2018 - 2021, USD Million
  • TABLE 286 LAMEA Arthritis Market by Country, 2022 - 2028, USD Million
  • TABLE 287 LAMEA Migraine Market by Country, 2018 - 2021, USD Million
  • TABLE 288 LAMEA Migraine Market by Country, 2022 - 2028, USD Million
  • TABLE 289 LAMEA Ophthalmic Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 290 LAMEA Ophthalmic Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 291 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 292 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 293 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 294 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 295 Brazil Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 296 Brazil Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 297 Brazil Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 298 Brazil Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 299 Brazil Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 300 Brazil Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 301 Brazil Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 302 Brazil Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 303 Argentina Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 304 Argentina Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 305 Argentina Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 306 Argentina Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 307 Argentina Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 308 Argentina Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 309 Argentina Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 310 Argentina Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 311 UAE Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 312 UAE Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 313 UAE Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 314 UAE Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 315 UAE Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 316 UAE Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 317 UAE Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 318 UAE Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 319 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 320 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 321 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 322 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 323 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 324 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 325 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 326 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 327 South Africa Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 328 South Africa Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 329 South Africa Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 330 South Africa Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 331 South Africa Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 332 South Africa Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 333 South Africa Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 334 South Africa Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 335 Nigeria Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 336 Nigeria Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 337 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 338 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 339 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 340 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 341 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 342 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 343 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 344 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 345 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 346 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 347 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 348 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 349 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 350 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 351 key information - Dr. Reddy's Laboratories Ltd.
  • TABLE 352 Key Information - Pfizer, Inc.
  • TABLE 353 Key Information - GlaxoSmithKline PLC
  • TABLE 354 Key Information - Bayer AG
  • TABLE 355 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 356 Key Information - Eli Lilly And Company
  • TABLE 357 Key Information - Sanofi S.A.
  • TABLE 358 KEY INFORMATION - ASTRAZENECA PLC
  • TABLE 359 key information - Viatris, Inc.
  • TABLE 360 KEY INFORMATION - MERCK & CO., INC.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Non-steroidal Anti-inflammatory Drugs Market Share by Route of Administration, 2021
  • FIG 3 Global Non-steroidal Anti-inflammatory Drugs Market Share by Route of Administration, 2028
  • FIG 4 Global Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2028, USD Million
  • FIG 5 Global Non-steroidal Anti-inflammatory Drugs Market Share by Distribution Channel, 2021
  • FIG 6 Global Non-steroidal Anti-inflammatory Drugs Market Share by Distribution Channel, 2028
  • FIG 7 Global Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2028, USD Million
  • FIG 8 Global Non-steroidal Anti-inflammatory Drugs Market Share by Disease Indication, 2021
  • FIG 9 Global Non-steroidal Anti-inflammatory Drugs Market Share by Disease Indication, 2028
  • FIG 10 Global Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2028, USD Million
  • FIG 11 Global Non-steroidal Anti-inflammatory Drugs Market Share by Region, 2021
  • FIG 12 Global Non-steroidal Anti-inflammatory Drugs Market Share by Region, 2028
  • FIG 13 Global Non-steroidal Anti-inflammatory Drugs Market by Region, 2018 - 2028, USD Million
  • FIG 14 Recent strategies and developments: Dr. Reddy's Laboratories Ltd.